260 related articles for article (PubMed ID: 28934664)
1. Targeted H
Deng Z; Tang M; Zhao L; Long Y; Wen Z; Cheng Y; Zheng H
Colloids Surf B Biointerfaces; 2017 Dec; 160():207-214. PubMed ID: 28934664
[TBL] [Abstract][Full Text] [Related]
2. Polydopamine coated hollow mesoporous silica nanoparticles as pH-sensitive nanocarriers for overcoming multidrug resistance.
Shao M; Chang C; Liu Z; Chen K; Zhou Y; Zheng G; Huang Z; Xu H; Xu P; Lu B
Colloids Surf B Biointerfaces; 2019 Nov; 183():110427. PubMed ID: 31408782
[TBL] [Abstract][Full Text] [Related]
3. pH-responsive selenium nanoparticles stabilized by folate-chitosan delivering doxorubicin for overcoming drug-resistant cancer cells.
Luesakul U; Puthong S; Neamati N; Muangsin N
Carbohydr Polym; 2018 Feb; 181():841-850. PubMed ID: 29254044
[TBL] [Abstract][Full Text] [Related]
4. Preparation of multilocation reduction-sensitive core crosslinked folate-PEG-coated micelles for rapid release of doxorubicin and tariquidar to overcome drug resistance.
Yi X; Zhao D; Zhang Q; Xu J; Yuan G; Zhuo R; Li F
Nanotechnology; 2017 Feb; 28(8):085603. PubMed ID: 28055982
[TBL] [Abstract][Full Text] [Related]
5. Folic acid-modified Prussian blue/polydopamine nanoparticles as an MRI agent for use in targeted chemo/photothermal therapy.
Lin X; Cao Y; Li J; Zheng D; Lan S; Xue Y; Yu F; Wu M; Zhu X
Biomater Sci; 2019 Jul; 7(7):2996-3006. PubMed ID: 31111139
[TBL] [Abstract][Full Text] [Related]
6. A novel high drug loading mussel-inspired polydopamine hybrid nanoparticle as a pH-sensitive vehicle for drug delivery.
Hou J; Guo C; Shi Y; Liu E; Dong W; Yu B; Liu S; Gong J
Int J Pharm; 2017 Nov; 533(1):73-83. PubMed ID: 28943209
[TBL] [Abstract][Full Text] [Related]
7. pH and Ultrasound Dual-Responsive Polydopamine-Coated Mesoporous Silica Nanoparticles for Controlled Drug Delivery.
Li X; Xie C; Xia H; Wang Z
Langmuir; 2018 Aug; 34(34):9974-9981. PubMed ID: 30056720
[TBL] [Abstract][Full Text] [Related]
8. Targeted doxorubicin nanotherapy strongly suppressing growth of multidrug resistant tumor in mice.
Nguyen DH; Lee JS; Bae JW; Choi JH; Lee Y; Son JY; Park KD
Int J Pharm; 2015 Nov; 495(1):329-335. PubMed ID: 26325307
[TBL] [Abstract][Full Text] [Related]
9. A H(+)-triggered bubble-generating nanosystem for killing cancer cells.
Yang L; Wen Z; Long Y; Huang N; Cheng Y; Zhao L; Zheng H
Chem Commun (Camb); 2016 Sep; 52(72):10838-41. PubMed ID: 27488856
[TBL] [Abstract][Full Text] [Related]
10. Enhanced Cytotoxicity of Folic Acid-Targeted Liposomes Co-Loaded with C6 Ceramide and Doxorubicin: In Vitro Evaluation on HeLa, A2780-ADR, and H69-AR Cells.
Sriraman SK; Pan J; Sarisozen C; Luther E; Torchilin V
Mol Pharm; 2016 Feb; 13(2):428-37. PubMed ID: 26702994
[TBL] [Abstract][Full Text] [Related]
11. Surface modification of doxorubicin-loaded nanoparticles based on polydopamine with pH-sensitive property for tumor targeting therapy.
Bi D; Zhao L; Yu R; Li H; Guo Y; Wang X; Han M
Drug Deliv; 2018 Nov; 25(1):564-575. PubMed ID: 29457518
[TBL] [Abstract][Full Text] [Related]
12. Fabricating polydopamine-coated MoSe
Chai S; Kan S; Sun R; Zhou R; Sun Y; Chen W; Yu B
Int J Nanomedicine; 2018; 13():7607-7621. PubMed ID: 30510420
[TBL] [Abstract][Full Text] [Related]
13. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
Ma X; Zhao Y; Ng KW; Zhao Y
Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
[TBL] [Abstract][Full Text] [Related]
14. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles.
Wu Y; Zhang Y; Zhang W; Sun C; Wu J; Tang J
Colloids Surf B Biointerfaces; 2016 Feb; 138():60-9. PubMed ID: 26655793
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity of folic acid conjugated hollow silica nanoparticles toward Caco2 and 3T3 cells, with and without encapsulated DOX.
Patel K; Sundara Raj B; Chen Y; Lou X
Colloids Surf B Biointerfaces; 2016 Apr; 140():213-222. PubMed ID: 26764104
[TBL] [Abstract][Full Text] [Related]
16. pH-Sensitive Delivery Vehicle Based on Folic Acid-Conjugated Polydopamine-Modified Mesoporous Silica Nanoparticles for Targeted Cancer Therapy.
Cheng W; Nie J; Xu L; Liang C; Peng Y; Liu G; Wang T; Mei L; Huang L; Zeng X
ACS Appl Mater Interfaces; 2017 Jun; 9(22):18462-18473. PubMed ID: 28497681
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of polydopamine modified and conventional chemical synthesis method in doxorubicin liposomes form the aspect of tumor targeted therapy.
Bi D; Zhao L; Li H; Guo Y; Wang X; Han M
Int J Pharm; 2019 Mar; 559():76-85. PubMed ID: 30677481
[TBL] [Abstract][Full Text] [Related]
18. Folate/N-acetyl glucosamine conjugated mesoporous silica nanoparticles for targeting breast cancer cells: A comparative study.
Kumar P; Tambe P; Paknikar KM; Gajbhiye V
Colloids Surf B Biointerfaces; 2017 Aug; 156():203-212. PubMed ID: 28531877
[TBL] [Abstract][Full Text] [Related]
19. Mussel-inspired polydopamine coated mesoporous silica nanoparticles as pH-sensitive nanocarriers for controlled release.
Zheng Q; Lin T; Wu H; Guo L; Ye P; Hao Y; Guo Q; Jiang J; Fu F; Chen G
Int J Pharm; 2014 Mar; 463(1):22-6. PubMed ID: 24393764
[TBL] [Abstract][Full Text] [Related]
20. Folic acid-capped PEGylated magnetic nanoparticles enter cancer cells mostly via clathrin-dependent endocytosis.
Allard-Vannier E; Hervé-Aubert K; Kaaki K; Blondy T; Shebanova A; Shaitan KV; Ignatova AA; Saboungi ML; Feofanov AV; Chourpa I
Biochim Biophys Acta Gen Subj; 2017 Jun; 1861(6):1578-1586. PubMed ID: 27919801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
